Summit Global Investments’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Summit Global Investments’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21,279	Closed	-$1.12M	–	285
2020 Q3	$1.12M	Buy	21,279 +49	+0.2%	+$3.02K	0.12%	123
2020 Q2	$1.3M	Buy	21,230 +4,800	+29%	+$278K	0.15%	101
2020 Q1	$929K	Sell	16,430 -1,300	-7%	-$74.1K	0.14%	89
2019 Q4	$1.01M	Buy	17,730 +1,750	+11%	+$92.8K	0.11%	116
2019 Q3	$855K	Buy	+15,980	New	+$930K	0.1%	161
2018 Q2	–	Sell	-13,900	Closed	-$616K	–	337
2018 Q1	$616K	Buy	+13,900	New	+$584K	0.1%	133

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Summit Global Investments's BSTC Position: Q4 2020 in Review

Summit Global Investments sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 21,279 shares — an estimated $1.12M sold.

Summit Global Investments first reported a position in BSTC in Q1 2018 and held it in 6 quarters. The position peaked at $1.3M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Summit Global Investments reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Summit Global Investments sold 21,279 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.12M.
Summit Global Investments first reported a position in BioSpecifics Technologies Corp. in Q1 2018 and held it in 6 quarters.
Summit Global Investments's BioSpecifics Technologies Corp. position peaked at $1.3M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Summit Global Investments's 13F filing for Q4 2020, filed 11 Feb 2021.